BACKGROUND: Exposure to environmental tobacco smoke (ETS) is associated with the development of serious health consequences in children with cancer due to preexisting disease and treatment-related vulnerabilities. The purpose of the current investigation was to identify predictors of non-participation in a randomized intervention trial to reduce ETS exposure among pediatric cancer patients. METHODS:One hundred fifty-three families of pediatric cancer patients met study eligibility criteria. Parents of 117 (76%) patients agreed to study participation, whereas 36 (24%) parents declined (non-participants). Data were collected with respect to participant sociodemographic, medical, and treatment-related characteristics. RESULTS: Univariate analyses indicated that families whose primary caregivers were females or smokers were more likely to be non-participants in the ETS reduction trial (P = 0.045 and P = 0.009, respectively). Medical features that significantly associated with study non-participation included CNS tumor diagnosis (P = 0.030), no history of chemotherapy (P = 0.012), history of surgery prior to study recruitment (P = 0.036), and having future radiation therapy planned post study recruitment (P = 0.009). Multivariable logistic regression modeling revealed that study non-participation was associated with the primary caregiver being a smoker (OR = 6.48, P = 0.002) or female (OR = 8.56, P = 0.023), and patient CNS tumor diagnosis (OR = 4.63, P = 0.021). CONCLUSIONS: Although a large percentage of eligible participants enrolled in the ETS reduction trial, findings suggest that future recruitment strategies of families should be tailored to parental smoking status and gender, as well as child diagnosis and treatment. (c) 2009 Wiley-Liss, Inc.
RCT Entities:
BACKGROUND: Exposure to environmental tobacco smoke (ETS) is associated with the development of serious health consequences in children with cancer due to preexisting disease and treatment-related vulnerabilities. The purpose of the current investigation was to identify predictors of non-participation in a randomized intervention trial to reduce ETS exposure among pediatric cancerpatients. METHODS: One hundred fifty-three families of pediatric cancerpatients met study eligibility criteria. Parents of 117 (76%) patients agreed to study participation, whereas 36 (24%) parents declined (non-participants). Data were collected with respect to participant sociodemographic, medical, and treatment-related characteristics. RESULTS: Univariate analyses indicated that families whose primary caregivers were females or smokers were more likely to be non-participants in the ETS reduction trial (P = 0.045 and P = 0.009, respectively). Medical features that significantly associated with study non-participation included CNS tumor diagnosis (P = 0.030), no history of chemotherapy (P = 0.012), history of surgery prior to study recruitment (P = 0.036), and having future radiation therapy planned post study recruitment (P = 0.009). Multivariable logistic regression modeling revealed that study non-participation was associated with the primary caregiver being a smoker (OR = 6.48, P = 0.002) or female (OR = 8.56, P = 0.023), and patientCNS tumor diagnosis (OR = 4.63, P = 0.021). CONCLUSIONS: Although a large percentage of eligible participants enrolled in the ETS reduction trial, findings suggest that future recruitment strategies of families should be tailored to parental smoking status and gender, as well as child diagnosis and treatment. (c) 2009 Wiley-Liss, Inc.
Authors: Melbourne F Hovell; Susan B Meltzer; Dennis R Wahlgren; Georg E Matt; C Richard Hofstetter; Jennifer A Jones; Eli O Meltzer; J Thomas Bernert; James L Pirkle Journal: Pediatrics Date: 2002-11 Impact factor: 7.124
Authors: Vida L Tyc; Leslee Throckmorton-Belzer; James L Klosky; Frances L Greeson; Shelly Lensing; Shesh N Rai; Melissa M Hudson Journal: J Child Health Care Date: 2004-12 Impact factor: 1.979
Authors: J P Neglia; A T Meadows; L L Robison; T H Kim; W A Newton; F B Ruymann; H N Sather; G D Hammond Journal: N Engl J Med Date: 1991-11-07 Impact factor: 91.245
Authors: B R O'Driscoll; P S Hasleton; P M Taylor; L W Poulter; H R Gattameneni; A A Woodcock Journal: N Engl J Med Date: 1990-08-09 Impact factor: 91.245
Authors: Jonathan P Winickoff; Valerie J Hillis; Judith S Palfrey; James M Perrin; Nancy A Rigotti Journal: Pediatrics Date: 2003-01 Impact factor: 7.124
Authors: Rochelle Yang; Barry L Carter; Tyler H Gums; Brian M Gryzlak; Yinghui Xu; Barcey T Levy Journal: BMC Med Res Methodol Date: 2017-07-10 Impact factor: 4.615
Authors: Rachel A Laws; Philip Vita; Kamalesh Venugopal; Chris Rissel; Daniel Davies; Stephen Colagiuri Journal: BMC Public Health Date: 2012-09-24 Impact factor: 3.295
Authors: Yizhao Ni; Andrew F Beck; Regina Taylor; Jenna Dyas; Imre Solti; Jacqueline Grupp-Phelan; Judith W Dexheimer Journal: J Am Med Inform Assoc Date: 2016-04-27 Impact factor: 4.497
Authors: Ruth Link-Gelles; Daniel Westreich; Allison E Aiello; Nong Shang; David J Weber; Corinne Holtzman; Karen Scherzinger; Arthur Reingold; William Schaffner; Lee H Harrison; Jennifer B Rosen; Susan Petit; Monica Farley; Ann Thomas; Jeffrey Eason; Christine Wigen; Meghan Barnes; Ola Thomas; Shelley Zansky; Bernard Beall; Cynthia G Whitney; Matthew R Moore Journal: SSM Popul Health Date: 2016-12
Authors: Ruth Link-Gelles; Daniel Westreich; Allison E Aiello; Nong Shang; David J Weber; Jennifer B Rosen; Tasneem Motala; Laurene Mascola; Jeffery Eason; Karen Scherzinger; Corinne Holtzman; Arthur L Reingold; Meghan Barnes; Susan Petit; Monica M Farley; Lee H Harrison; Shelley Zansky; Ann Thomas; William Schaffner; Lesley McGee; Cynthia G Whitney; Matthew R Moore Journal: BMJ Open Date: 2017-08-28 Impact factor: 2.692
Authors: Sasha G Hutchinson; Constant P van Schayck; Jean W M Muris; Frans J M Feron; Edward Dompeling Journal: BMC Pediatr Date: 2018-01-31 Impact factor: 2.125